缺铁程度对口服铁剂吸收的影响
该研究纳入37例非妊娠期女性铁缺乏症患者和13例健康女性,分析缺铁性贫血(IDA)、缺铁性红细胞生成/储存铁不足(ID/IDE)及正常对照者的Hepcidin水平和口服铁剂吸收试验。结果显示IDA组Hepcidin显著低于ID/IDE组和正常对照,铁缺乏程度影响口服铁剂吸收,Hepcidin较口服铁剂吸收试验更能区分不同缺铁程度患者的铁吸收水平。
要点
- IDA组Hepcidin中位数4.9 μg/L,显著低于ID/IDE组26.98 μg/L和正常对照69.89 μg/L。
- ID/IDE组与正常对照组Hepcidin差异无统计学意义(校正后P=0.220)。
- 胃肠功能正常者铁缺乏越重,口服铁剂吸收越多,Hepcidin较C2-C0更能区分铁吸收水平。
核心结论
- 铁缺乏程度影响口服铁剂吸收,ID/IDE组较IDA组铁吸收减缓。
- 胃肠功能正常者铁缺乏越重,口服铁剂吸收越多。
- Hepcidin较口服铁剂吸收试验的C2-C0更能区分不同铁缺乏程度患者的铁吸收水平。
研究设计与样本
- 纳入2018年7月至2020年6月中国医学科学院血液病医院贫血中心门诊确诊铁缺乏症的非妊娠期女性患者37例,健康查体女性13例为对照。
- 分析IDA、ID/IDE及正常对照者Hepcidin水平并进行口服铁剂吸收试验,比较服铁后2 h血清铁(C2)与基线血清铁(C0)差值。
主要发现
- IDA、ID/IDE、正常对照组Hepcidin中位数分别为4.9(2.17~32.86)、26.98(11.02~49.71)、69.89(42.23~138.96)μg/L(P<0.001)。
- IDA组Hepcidin低于ID/IDE组(校正后P=0.005)和正常对照组(校正后P<0.001),ID/IDE组与正常对照组差异无统计学意义(校正后P=0.220)。
- 口服铁剂吸收试验IDA、ID/IDE及正常对照组C2-C0平均值分别为(35.30±21.68)、(37.90±14.06)、(23.57±10.14)μmol/L,差异无统计学意义(P=0.130)。
- 多重线性回归显示C0、血清铁蛋白(SF)、可溶性转铁蛋白受体(sTFR)和HGB是铁缺乏症患者Hepcidin的独立影响因素,方程:Hepcidin=-31.842-0.642*C0+2.239*SF+1.778*sTFR+0.365*HGB-0.274*网织红细胞血红蛋白含量(RET-HB)。
- 未发现C2-C0的独立影响因素。
临床怎么用
- 对胃肠功能正常的铁缺乏症患者,缺铁程度越重口服铁剂吸收越多,ID/IDE患者吸收较IDA患者减缓。
- Hepcidin可作为区分不同缺铁程度患者口服铁吸收水平的参数,优于口服铁剂吸收试验的C2-C0。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the effect of iron deficiency level for oral iron absorption in iron deficient patients. Methods: 37 non-pregnant female patients who were diagnosed with iron deficiency and 13 healthy females who completed their physical examination at the outpatient department of the Anemia Center of the Institute of Hematology & Blood Diseases Hospital from July 2018 to June 2020 were included. Hepcidin and C2-C0 of oral iron absorption test were analyzed in different iron deficiency and serum ferritin level. Results: The median of Hepcidin in IDA, ID/IDE and healthy control group were 4.9 (2.17-32.86) , 26.98 (11.02-49.71) and 69.89 (42.23-138.96) μg/L (P<0.001) , respectively. Hepcidin level of IDA group was lower than that of ID/IDE group (adjusted P=0.005) and healthy control (adjusted P<0.001) . Hepcidin level of ID/IDE group had no significant difference compared with healthy control (adjusted P=0.22) . The mean of C2-C0 in IDA, ID/IDE and healthy control group were (35.30±21.68) , (37.90±14.06) and (23.57±10.14) μmol/L (P=0.130) , respectively. Multilinear regression analysis showed C0, SF, sTFR and HGB were independent factors for Hepcidin in iron deficient patients, with an equation of Hepcidin=-31.842-0.642*C0+2.239*SF+1.778*sTFR+0.365*HGB-0.274*RET-HB. We didn't find independent factor of C2-C0. Conclusion: The degree of iron deficiency had an effect on oral iron absorption. Patients of ID/IDE group absorbed iron more slowly than patients of IDA group. Iron deficient patients with normal gastrointestinal function absorbed more iron by oral administration when they were in a more serious iron deficient stage. Hepcidin was a better parameter to distinguish iron absorption level among different iron deficient patients than C2-C0 of oral iron absorption test. 目的: 研究铁缺乏症患者缺铁程度对口服铁剂吸收的影响。 方法: 纳入2018年7月至2020年6月于中国医学科学院血液病医院贫血中心门诊就诊并确诊铁缺乏症的非妊娠期女性患者37例,以13例健康查体女性为正常对照,分析缺铁性贫血(IDA)、缺铁性红细胞生成/储存铁不足(IDE/ID)患者及正常对照者Hepcidin水平并进行口服铁剂吸收试验(OIAT),比较服铁后2 h血清铁(C2)与基线血清铁(C0)差值。 结果: IDA、ID/IDE、正常对照组Hepcidin中位数分别为4.9(2.17~32.86)、26.98(11.02~49.71)、69.89(42.23~138.96)μg/L(P<0.001),IDA组Hepcidin低于ID/IDE组(校正后P=0.005)和正常对照组(校正后P<0.001),但ID/IDE组与正常对照组差异无统计学意义(校正后P=0.220);OIAT IDA、ID/IDE及正常对照组C2-C0平均值分别为(35.30±21.68)、(37.90±14.06)、(23.57±10.14)μmol/L,差异无统计学意义(P=0.130)。多重线性回归分析显示C0、血清铁蛋白(SF)、可溶性转铁蛋白受体(sTFR)和HGB是铁缺乏症患者Hepcidin的独立影响因素,Hepcidin=-31.842-0.642*C0+2.239*SF+1.778*sTFR+0.365*HGB-0.274*网织红细胞血红蛋白含量(RET-HB)。未发现C2-C0的独立影响因素。 结论: 铁缺乏程度影响口服铁剂吸收,胃肠功能正常者铁缺乏越重,口服铁剂吸收越多,ID/IDE较IDA铁吸收减缓。Hepcidin较OIAT更能区分不同铁缺乏程度的口服铁吸收。.
引用
- Hu J, Hu XR, Li XX, et al. [Effect of iron deficiency level on oral iron absorption]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34218583. doi:10.3760/cma.j.issn.0253-2727.2021.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。